Ingrid Zhang has been appointed Chief Executive Officer of Legend Biotech after a board-led search, Legend said on September 15. The company’s announcement says Zhang will guide the pipeline and long-term growth strategy; Reuters reported that the company selected the Novartis veteran as its new CEO.\n\nThe board’s brief is specific: advance Legend’s pipeline, expand its impact, continue developing CARVYKTI and deliver sustained growth. The announcement does not set out a predecessor or an effective date, so the useful signal is the mandate rather than a staged handover.\n\nA pipeline-led mandate\n\nZhang arrives with experience in global biopharma and a remit that connects product development with commercial scale. For a company built around cell therapy, that combination matters: the CEO role sits at the junction of scientific execution, patient impact and the discipline required to grow a platform. The board said its search concluded that Zhang was the right leader for the next phase.\n\nHer appointment follows a run of healthcare leadership changes that have put operating depth and governance in the same frame, including Health Catalyst’s move to Simeon Kohl.
Leadership · C-Suite
Legend Biotech appoints Ingrid Zhang as CEO
The cell-therapy company has chosen a Novartis veteran to lead its pipeline, advance CARVYKTI and carry its long-term growth strategy into its next phase.
EDThe Encafeinados Desk3 min read2 sources

Go deeper
Sources
Keep reading
Related stories
Leadership · AppointmentsBrett Yormark named CEO of Milan Sports & EntertainmentRedBird brings its Milan sports and entertainment holdings under one platform, giving the former Brooklyn Nets executive a portfolio-wide mandate spanning venues, partnerships and future investments.
Leadership · AppointmentsRumo confirms Daniel Rockenbach as permanent CEOThe Brazilian rail operator has ended Rockenbach’s interim period and confirmed a 16-year company veteran through the 2028 annual meeting, following a committee recommendation.
Leadership · AppointmentsKlarna names Robinhood finance leader Chris Koegel as CFOThe former Robinhood finance executive will take over in January, subject to regulatory approval, after Niclas Neglén’s planned departure following six years as Klarna CFO.